Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Completed
National Cancer Institute (NCI)
Phase 2
1998-01-01
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of
chemotherapy or radiation therapy and kill more cancer cells.
PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to
see how well it works when given with chemotherapy or radiation therapy in treating patients
with high-risk hematologic cancer.
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Completed
Case Comprehensive Cancer Center
Phase 2
1998-01-01
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of
chemotherapy or radiation therapy and kill more cancer cells.
PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to
see how well it works when given with chemotherapy or radiation therapy in treating patients
with high-risk hematologic cancer.
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Completed
Roswell Park Cancer Institute
Phase 2
1998-06-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer
cells. Umbilical cord blood transplantation may be able to replace cells destroyed by
chemotherapy or radiation therapy.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy, radiation therapy, and
umbilical cord blood transplantation in treating patients who have hematologic cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
